| Literature DB >> 30616642 |
José L Ruiz1,2, Rakiswendé S Yerbanga3, Thierry Lefèvre3,4, Jean B Ouedraogo3, Victor G Corces5, Elena Gómez-Díaz6,7.
Abstract
BACKGROUND: Infection by the human malaria parasite leads to important changes in mosquito phenotypic traits related to vector competence. However, we still lack a clear understanding of the underlying mechanisms and, in particular, of the epigenetic basis for these changes. We have examined genome-wide distribution maps of H3K27ac, H3K9ac, H3K9me3 and H3K4me3 by ChIP-seq and the transcriptome by RNA-seq, of midguts from Anopheles gambiae mosquitoes blood-fed uninfected and infected with natural isolates of the human malaria parasite Plasmodium falciparum in Burkina Faso.Entities:
Keywords: ChIP-seq; Epigenome; Gene regulation; Histone modifications; Human malaria; Mosquitoes; RNA-seq; Transcriptome
Mesh:
Substances:
Year: 2019 PMID: 30616642 PMCID: PMC6322293 DOI: 10.1186/s13072-018-0250-9
Source DB: PubMed Journal: Epigenetics Chromatin ISSN: 1756-8935 Impact factor: 4.954
Fig. 1Association between histone modification profiles and gene expression regulation in A. gambiae. a Annotation of MACS2 ChIP-seq peaks for each histone modification to genomic features: TSS-Promoters, TTSs, Intergenic, Intron and Exon regions. The plot corresponds to the infected condition; data for the uninfected are given in Additional file 4: Figure S1. b Density plot showing the position (Kb upstream) of MACS2 peaks for each histone modification with respect to the ATG protein initiation codon of the nearest downstream gene. Same as above, data are for the infected condition. c Heatmap of emission parameters from ChromHMM analysis using a four chromatin states model based on histone modification enrichment patterns in the infected condition. The predicted states are: Deplet (depleted, low levels of all hPTMs), Repr (repressive, H3K9me3 enrichment), Biv (bivalent, H3K4me3/H3K9me3 enrichment) and Act (active, H3K27ac/H3K9ac/H3K4me3 enrichment). Darker blue indicates higher enrichment of a particular histone modification. d Heatmap showing the overlap of various genomic features, including MACS2 peaks located in promoters (2 Kb from the ATG) or gene bodies in the infected condition, with the predicted chromatin states. Darker blue in the first column indicates higher percentage of the genome overlapped by a given state. For other columns, it indicates the likelihood of finding a particular chromatin state in each genomic feature compared to what it would be expected by chance. e Heatmaps showing mRNA levels (left) and histone modification enrichment profiles (right) of genes displaying a MACS2 peak in the promoter or the gene body. Data correspond to the infected condition. Genes are ordered by mRNA levels. ChIP-seq enrichment at the promoters and the gene bodies is normalized (RPKM) and input-corrected. Data are log2-scaled and mean-centered. Spearman rank correlation coefficient (rho) and corresponding P value are shown for the association between each histone modification enrichment levels and mRNA levels. The variance in mRNA levels explained by the combined and individual enrichment levels of various histone modifications is shown, according to a linear regression model considering gene expression as response and ChIP-seq enrichment as covariate. f Heatmaps showing histone modification enrichment profiles at high and medium expressed genes in the infected condition. Genes are ordered by the percentage of the body containing introns and exons. Average profile plots show density of normalized (RPKM) and input-corrected ChIP-seq reads for each histone modification at high and medium expressed genes (top) and at those genes classified by the percentage of the gene body containing introns (right)
Fig. 2Changes in histone modification enrichment in response to infection. a Density plot showing the position (Kb upstream) of differential diffReps regions for each histone modification with respect to the ATG initiation codon of the nearest downstream gene. b Annotation of diffReps regions for each histone modification to genomic features: TSS-Promoters, TTSs, Intergenic, Intron and Exon regions. diffReps regions located − 2 Kb/+ 0.1 Kb from the ATG are annotated to TSS-Promoter regions. c Barplot showing the number and location of high-confidence diffReps regions and the chromatin state transitions between conditions associated with the region. d Profile plots showing predicted chromatin states in infected (left) and control (right) conditions at genes encoding for immune-related factors [34]. The graphs represent chromatin state fold enrichment (log(observed/expected)) with respect to the scaled gene bodies ± 10 Kb. e, f Histone enrichment profiles in the regions containing the CTLSE1 (AGAP000929) and DEF1 (AGAP011294) encoding genes. Tracks show normalized/input-corrected ChIP-seq signals and RNA-seq mapped read counts for each condition. The location of diffReps regions, MACS2 peaks and predicted chromatin states for each condition are included. All tracks are shown at equal scale
Fig. 3Association between histone modification differential enrichment and changes in gene expression. a Heatmaps showing clusters of genes (− 2 Kb) grouped by unique histone modification profiles identified in the soft clustering analysis (left) and corresponding changes in mRNA levels (right). ChIP-seq enrichment at the promoters and gene bodies is normalized (RPKM) and input-corrected. The signal corresponds to the ratio of ChIP-seq and mRNA levels in the infected versus the control condition. Data are log2-scaled and mean-centered. Representative profiles for each cluster showing various combinations of histone modification enrichment are included. All the profiles resulting from the soft clustering analysis are shown in Additional file 4: Figure S5. b Ratio of gene expression and histone modification enrichment between infected and control conditions for Mfuzz clusters more highly expressed in infected (left) and control (right) conditions. Data are the log2-scaled ratio between the infected and the control as in a. Spearman rank correlation coefficient (rho) and corresponding P value are shown for significant associations between histone modification enrichment and mRNA levels. c Histone enrichment profiles in the region containing the AGAP009887-encoding gene. Tracks show normalized/input-corrected ChIP-seq signals and RNA-seq mapped reads counts for each condition. The location of diffReps regions, MACS2 peaks, predicted transcription factor binding sites and predicted chromatin states for infected and control conditions are included. All tracks are shown at equal scale
Fig. 4Significant differential gene expression and association with histone modifications differential enrichment. a, b Histone enrichment profiles in the regions containing the IAP7 (AGAP007293) and Argonaute 4 (AGAP011717) encoding genes. Tracks show normalized/input-corrected ChIP-seq signals and normalized RNA-seq mapped reads counts for each condition. The location of diffReps regions, MACS2 peaks, predicted transcription factor binding sites and predicted chromatin states for each condition are included. All tracks are shown at equal scale
List of consensus motifs corresponding to known transcription factors significantly enriched in the set of differential histone-modified regions that are associated with P. falciparum infection
| Histone | Motif | % Targets/background | TF BS predicted (score) | FlyBase record | Function | |
|---|---|---|---|---|---|---|
|
| CGTTCCCYWTTT | 1E−23 | 18.40/1.06 | http://flybase.org/reports/FBgn0001320 | Development, gene expression | |
| AACKATTT | 1E−23 | 18.40/1.02 |
| Development, gene expression, reproduction, response to stimulus | ||
| GTGCGTRA | 1E−23 | 18.40/1.20 |
| Gene expression, nucleus | ||
| GCGATAGA | 1E−21 | 20.80/1.68 |
| Development, gene expression, metabolism | ||
| MCCGAGCN | 1E−20 | 16.00/0.64 |
| Immune system, development, gene expression | ||
| TAATCCRY | 1E−19 | 16.00/0.93 |
| Gene expression, other molecular function | ||
| CATCCTGGCG | 1E−17 | 24.00/3.41 |
| Development, gene expression, signaling, response to stimulus | ||
| TCCTTCGA | 1E−15 | 17.60/2.23 |
| Development, reproduction, response to stimulus, cell organization–biogenesis | ||
| CTTGTTCTTC | 1E−15 | 13.60/0.58 |
| Signaling, gene expression, immune system | ||
| TTCGTAATAC | 1E−15 | 13.60/1.46 |
| Development, gene expression, transcription factor | ||
| GCTTGCTY | 1E−14 | 16.80/2.34 |
| Development, biogenesis | ||
| AGCTTTAA | 1E−12 | 15.70/2.29 |
| Development, gene expression, transcription factor | ||
|
| GGCTCGTC | 1E−29 | 11.74/0.43 |
| Development, gene expression, DNA binding | |
| ATTTTTCCCC | 1E−21 | 9.39/0.65 |
| Immune system, development, gene expression | ||
| AGAACAGTAA | 1E−21 | 9.39/0.40 |
| Development, gene expression | ||
| GTGCAGCTCG | 1E−21 | 9.39/0.65 |
| Development, gene expression, DNA binding | ||
| CAAAAACGCAAC | 1E−21 | 9.39/0.67 |
| Development, gene expression, transcription factor | ||
| CTATGTTT | 1E−16 | 9.86/0.84 |
| Signaling, gene expression, immune system | ||
| TCGATCGTCG | 1E−15 | 7.51/0.00 |
| Development, gene expression, DNA binding, transcription factor, cell cycle, DNA metabolism | ||
| ATWTCTGC | 1E−13 | 8.45/1.00 |
| Development, biogenesis | ||
| CTTCADTGCGGA | 1E−13 | 6.57/0.66 |
| Development, gene expression, reproduction | ||
| CACGAAGT | 1E− 12 | 12.68/2.32 |
| Development, reproduction | ||
|
| ARTTTTGTGT | 1E−30 | 5.16/0.27 |
| Development, gene expression, reproduction, response to stimuli | |
| TTTGATTCGTAA | 1E−30 | 5.16/0.28 |
| Development, gene expression | ||
| CTTCTTGCCCGA | 1E−23 | 5.34/0.49 |
| Development, gene expression, reproduction | ||
| CGAARAAGAR | 1E−18 | 5.34/0.56 |
| Development, gene expression, response to stimulus, signaling, immune system | ||
| TCCTCGTCGTTG | 1E−16 | 7.55/1.60 |
| Other molecular function | ||
|
| AGCGCCTGGT | 1E−26 | 8.82/0.61 |
| Development, gene expression, response to stimulus, signaling | |
| YCTGTGACCG | 1E−24 | 8.46/0.59 |
| Development, gene expression, DNA binding, transport/localization, transcription facto | ||
| TCYKGWAKCKGA | 1E−24 | 8.46/0.58 |
| Development, gene expression, response to stimulus, signaling, immune system, cell cycle/proliferation, DNA binding | ||
| ACTCCAGATA | 1E−21 | 7.72/0.57 |
| Development, gene expression, protein metabolism, cell organization/biogenesis, enzyme | ||
| CTAYTTAT | 1E−21 | 7.72/0.18 |
| Development, gene expression, transcription factor | ||
| ATCTCGGG | 1E−21 | 7.72/0.53 |
| Development, gene expression, immune system, response to stimulus, transcription factor | ||
| CATTCGAC | 1E−21 | 9.56/0.81 |
| Development, gene expression, other molecular function, DNA binding, cell cycle/proliferation | ||
| RCGAAATTTTTG | 1E−20 | 7.35/0.22 |
| Development, gene expression, response to stimulus, transcription factor, DNA binding, immune system | ||
| TTAGACGA | 1E−20 | 7.35/0.40 |
| Development, gene expression, other molecular function, DNA binding, transcription factor |